John Lunger John Lunger is chief patient supply officer for Adaptimmune Therapeutics. From the AuthorSourcing & ProcurementCOVID-19 and the Impact on Supply Chains for Autologous Cell TherapiesThe chain of custody for live cells is critical to ensuring the safe and timely treatment of patients.Page 1 of 1
